View Related Documents

Abstract

The effects of some phosphodiesterase (PDE) inhibitors (dipyridamole, theophylline, papaverine and SH-869) on prostacyclin (PGI2) production have been studied in vitro and in vivo. PGI2 was bioassayed by Vane's superfusion technique. In rabbit aortic rings, only dipyridamole in concentrations from 1 to 12 µM was able to stimulate PGI2 biosynthesis in a dose-dependent manner. This effect was also detected with so-called ldquoexhaustedrdquo rabbit aortic rings. The other PDE inhibitors used, both in µM and mM concentration, did not affect PGI2 biosynthesis. Dipyridamole was found to increase PGI2 production in healthy volunteers, when given both by infusion (8 µg/kg/min × 2 h) and by oral administration (375 mg/day for seven days). Circulating PGI2 and PGI2 production induced by a 3-min period of ischaemia were increased by an average of 137% (p<0.001) and="" 30.8%="">p<0.001) respectively.="" saline="" and="" theophylline="" (as="" aminophylline)="" infusions="" used="" as="" controls="" did="" not="" affect="">2 production.

Key words  dipyridamole - prostacyclin - phosphodiesterase inhibitors - theophylline - antiaggregating agents - ischaemia

Fulltext Preview

Image of the first page of the fulltext document